In the same way, the inhibition of TNK2 in osteosarcoma cells partly counteracted the enhancing impact of ZNF692 overexpression on P-MEK1/2 and P-ERK1/2 (Fig. 6J-L). Here, MAPK3 is linked to osteosarcoma.